In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies to produce Victoza, also known as liraglutide, following a proposal by the ...

As the sale of weight loss drugs skyrocket around the country, Illinois’ attorney general is saying buyer beware. Sales of ...

On the one hand, its impressive business performance can make investors ponder potential life-changing investment returns. Conversely, feeling confident in Hims & Hers Health can sometimes be ...

Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that shape the U.S. drug market. Her job, ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Hims & Hers' robust Q3 2024 performance, driven by a 44% increase in subscribers and 77% y/y revenue growth, underscores its ...

A new GLP-1 generic is entering the U.S. market amid ... outperformed Novo Nordisk's diabetes drug Ozempic (which shares Wegovy's active ingredient) in weight reduction. That research analyzed ...

A less expensive, generic version of the GLP-1 medication Victoza is coming to market Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

My weight concerns mainly injure my considerable vanity, and I’m not about to outsource my self-esteem issue to Big Pharma if ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?